Y. Liu, X. Tian, G. Mao, X. Fang, M. Fung et al., Peroxisome Proliferator-Activated Receptor-?? Ameliorates Pulmonary Arterial Hypertension by Inhibiting 5-Hydroxytryptamine 2B Receptor, Hypertension, vol.60, issue.6, pp.1471-1478, 2012.
DOI : 10.1161/HYPERTENSIONAHA.112.198887

J. Launay, P. Hervé, K. Peoc-'h, C. Tournois, J. Callebert et al., Function of the serotonin 5-hydroxytryptamine 2B receptor in pulmonary hypertension, Nature Medicine, vol.13, issue.10, pp.1129-1135, 2002.
DOI : 10.1038/76282

J. Crossno, . Jr, C. Garat, J. Reusch, K. Morris et al., Rosiglitazone attenuates hypoxia-induced pulmonary arterial remodeling, AJP: Lung Cellular and Molecular Physiology, vol.292, issue.4, pp.885-897, 2007.
DOI : 10.1152/ajplung.00258.2006

G. Baxter, Novel discriminatory ligands for 5-HT2B receptors, Behavioural Brain Research, vol.73, issue.1-2, pp.149-152, 1996.
DOI : 10.1016/0166-4328(96)00087-3

A. Linder, G. Gaskell, T. Szasz, J. Thompson, and S. Watts, Serotonin Receptors in Rat Jugular Vein: Presence and Involvement in the Contraction, Journal of Pharmacology and Experimental Therapeutics, vol.334, issue.1
DOI : 10.1124/jpet.109.163014

J. Launay, P. Hervé, J. Callebert, Z. Mallat, C. Collet et al., Serotonin 5-HT2B receptors are required for bone-marrow contribution to pulmonary arterial hypertension, Blood, vol.119, issue.7, pp.1772-1780, 2012.
DOI : 10.1182/blood-2011-06-358374
URL : https://hal.archives-ouvertes.fr/inserm-00996752